0001179110-19-006512.txt : 20190522 0001179110-19-006512.hdr.sgml : 20190522 20190522175552 ACCESSION NUMBER: 0001179110-19-006512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190520 FILED AS OF DATE: 20190522 DATE AS OF CHANGE: 20190522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toselli Richard M. CENTRAL INDEX KEY: 0001710549 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37350 FILM NUMBER: 19847044 MAIL ADDRESS: STREET 1: C/O INVIVO THERAPEUTICS HOLDINGS CORP. STREET 2: 1 KENDALL SQUARE, SUITE B14402 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP. CENTRAL INDEX KEY: 0001292519 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-863-5524 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Design Source, Inc. DATE OF NAME CHANGE: 20040602 4 1 edgar.xml FORM 4 - X0306 4 2019-05-20 0 0001292519 INVIVO THERAPEUTICS HOLDINGS CORP. NVIV 0001710549 Toselli Richard M. C/O INVIVO THERAPEUTICS HOLDINGS CORP. ONE KENDALL SQUARE, SUITE B14402 CAMBRIDGE MA 02139 0 1 0 0 See Remarks Common Stock 2019-05-20 4 F 0 78 1.10 D 10615 D Common Stock 5228 I By 401(k) Plan Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 250 stock-settled RSUs. Between January 1, 2018 and May 22, 2019, the reporting person acquired 5,228 shares of NVIV common stock under the NVIV 401(k) plan. The information in this report isbased on a plan statement dated as of May 22, 2019. President and Chief Executive Officer /s/ Heather Hamel, Attorney-in-Fact 2019-05-22